Patents by Inventor Jasna Kriz

Jasna Kriz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of SRSF3 agents for the treatment and/or prevention of neurological conditions, cancer, bacterial infections or viral infections
    Patent number: 11530258
    Abstract: The present description relates to the use of a SRSF3 agent for regulating the function of a myeloid cell, such as a microglial cell and/or monocyte, for treating neurological conditions, cancers, bacterial infections and viral infections wherein the SRSF3 agent inhibits expression or function of SRSF3.
    Type: Grant
    Filed: November 15, 2018
    Date of Patent: December 20, 2022
    Assignee: Université Laval
    Inventors: Jasna Kriz, Hejer Boutej
  • USE OF SRSF3 AGENTS FOR THE TREATMENT AND/OR PREVENTION OF NEUROLOGICAL CONDITIONS, CANCER, BACTERIAL INFECTIONS OR VIRAL INFECTIONS
    Publication number: 20210171615
    Abstract: The present description relates to the use of a SRSF3 agent for regulating the function of a myeloid cell, such as a microglial cell and/or monocyte, for treating neurological conditions, cancers, bacterial infections and viral infections wherein the SRSF3 agent inhibits expression or function of SRSF3.
    Type: Application
    Filed: November 15, 2018
    Publication date: June 10, 2021
    Applicant: Université Laval
    Inventors: Jasna KRIZ, Hejer BOUTEJ
  • Therapy for stroke
    Publication number: 20040235801
    Abstract: The present invention relates to a method for reducing symptoms related to stroke, this therapy comprising the administration of a therapeutically effective amount of at least two compounds selected from the group of an inhibitor of microglial activation, an antiglutaminergic agent and a voltage gated calcium channel blocker to a patient suffering from a neurodegenerative disease. The present invention also relates to a composition for reducing symptoms related to stroke, comprising a therapeutically effective amount of at least two compounds selected from the group of an inhibitor of microglial activation, an antiglutaminergic agent and a voltage gated calcium channel blocker in association with a pharmaceutically acceptable carrier.
    Type: Application
    Filed: March 1, 2004
    Publication date: November 25, 2004
    Inventors: Jean-Pierre Julien, Jasna Kriz
  • Therapy for neurodegenerative diseases
    Publication number: 20030083318
    Abstract: The present invention relates to a method for reducing symptoms related to a neurodegenerative disease and/or treating a neurodegenerative disease, this therapy comprising the administration of a therapeutically effective amount of at least two compounds selected from the group of an inhibitor of microglial activation, an antiglutominergic agent and a voltage gated calcium channer blocker to a patient suffering from a neurodegenerative disease. The present invention also relates to a composition for reducing symptoms related to a neurodegenerative disease and/or treating a neurodegenerative disease, comprising a therapeutically effective amount of at least two compounds selected from the group of an inhibitor of microglial activation, an antiglutaminergic agent and a voltage gated calcium channel blocker in association with a pharmaceutically acceptable carrier.
    Type: Application
    Filed: October 25, 2002
    Publication date: May 1, 2003
    Inventors: Jean-Pierre Julien, Jasna Kriz